Apogee Therapeutics (APGE, $68.43) was one of top quarterly gainers, jumping +14 to $68.43 per share. A.I.dvisor analyzed 875 stocks in the Biotechnology Industry over the last three months, and discovered that of them (6) charted an Uptrend while of them (3) trended down.